Journal ArticleDOI
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
Frank C. Detterbeck,Michael A. Jantz,Michael B. Wallace,Johan Vansteenkiste,Gerard A. Silvestri +4 more
TLDR
In patients with extensive mediastinal infiltration, invasive staging is not needed and patients with a peripheral clinical stage I NSCLC do not usually need invasive confirmation of mediastsinal nodes unless a PET scan finding is positive in the nodes.About:
This article is published in Chest.The article was published on 2007-09-01. It has received 672 citations till now. The article focuses on the topics: Lung cancer staging & Mediastinoscopy.read more
Citations
More filters
Journal ArticleDOI
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis,Elisabeth Brambilla,Masayuki Noguchi,Andrew G. Nicholson,Kim R. Geisinger,Yasushi Yatabe,David G. Beer,Charles A. Powell,Gregory J. Riely,Paul Van Schil,Kavita Garg,John H. M. Austin,Hisao Asamura,Valerie W. Rusch,Fred R. Hirsch,Giorgio V. Scagliotti,Tetsuya Mitsudomi,Rudolf M. Huber,Yuichi Ishikawa,James R. Jett,Montserrat Sanchez-Cespedes,Jean-Paul Sculier,Takashi Takahashi,Masahiro Tsuboi,Johan Vansteenkiste,Ignacio I. Wistuba,Pan-Chyr Yang,Denise R. Aberle,Christian Brambilla,Douglas B. Flieder,Wilbur A. Franklin,Adi F. Gazdar,Michael K. Gould,Philip S. Hasleton,Douglas W. Henderson,Bruce E. Johnson,David A Johnson,Keith M. Kerr,Keiko Kuriyama,Jin Soo Lee,Vincent A. Miller,Iver Petersen,Victor L. Roggli,Rafael Rosell,Nagahiro Saijo,Erik Thunnissen,M. Tsao,David Yankelewitz +47 more
TL;DR: This new adenocarcinoma classification is needed to provide uniform terminology and diagnostic criteria, especially for bronchioloalveolar carcinoma (BAC), the overall approach to small nonresection cancer specimens, and for multidisciplinary strategic management of tissue for molecular and immunohistochemical studies.
Journal ArticleDOI
Methods for Staging Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Gerard A. Silvestri,Anne V. Gonzalez,Michael A. Jantz,Mitchell L. Margolis,Michael K. Gould,Lynn T. Tanoue,Loren J. Harris,Frank C. Detterbeck +7 more
TL;DR: It is demonstrated that PET scanning is more accurate than CT scanning, but tissue biopsy is still required to confirm PET scan findings, and evidence suggests that more complete staging improves patient outcomes.
Journal ArticleDOI
Management of non-small-cell lung cancer: recent developments.
TL;DR: The evolution of lung cancer staging towards more non-invasive, endoscopy-based, and image-based methods, and the development of stage-adapted treatment is discussed, with an emphasis on targeted therapies based on the assumption that a treatable driver mutation or gene rearrangement is present within the tumour.
Journal ArticleDOI
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.
Paul De Leyn,Christophe Dooms,Jarosław Kużdżał,Didier Lardinois,Bernward Passlick,Ramón Rami-Porta,Akif Turna,Paul Van Schil,Frederico Venuta,David A. Waller,Walter Weder,Marcin Zieliński +11 more
TL;DR: A revision of the ESTS guidelines was needed because more evidence of the different mediastinal staging technique has become available and both endoscopic techniques and surgical procedures are available, but their negative predictive value is lower compared with the results obtained in baseline staging.
Journal ArticleDOI
Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis
TL;DR: EBUS-TBNA was an accurate, safe and cost-effective tool in lung cancer staging and the selection of patients who had positive results of suspected lymph node metastasis in CT or PET may improve the sensitivity of EBUS- TBNA.
References
More filters
Journal ArticleDOI
Real-time Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Mediastinal and Hilar Lymph Nodes
Kazuhiro Yasufuku,Masako Chiyo,Yasuo Sekine,Prashant N. Chhajed,Kiyoshi Shibuya,Toshihiko Iizasa,Takehiko Fujisawa +6 more
TL;DR: Real-time CP-EBUS-guided TBNA of mediastinal and hilar lymph nodes is a novel approach that is safe and has a good diagnostic yield and this new ultrasound puncture bronchoscope has an excellent potential for assisting in safe and accurate diagnostic interventional bronchoscopy.
Journal ArticleDOI
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
Michael K. Gould,Ware G. Kuschner,Chara E. Rydzak,Courtney C. Maclean,Anita N Demas,Hidenobu Shigemitsu,Jo Kay Chan,Douglas K Owens +7 more
TL;DR: A synthesis of 39 studies found that FDG-PET was more accurate than CT for identifying lymph node involvement and CT was more sensitive but less specific in patients with lymph node enlargement on CT.
Journal ArticleDOI
Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes
TL;DR: In this paper, the authors used real-time endobronchial ultrasound (EBUS) guidance to increase the ability to sample mediastinal lymph nodes and hence to determine a diagnosis.
Journal ArticleDOI
Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer
Kazuhiro Yasufuku,Masako Chiyo,Eitetsu Koh,Yasumitsu Moriya,Akira Iyoda,Yasuo Sekine,Kiyoshi Shibuya,Toshihiko Iizasa,Takehiko Fujisawa +8 more
TL;DR: Evaluated EBUS-TBNA is a safe and sensitive method for lymph node staging in patients with lung cancer which spares invasive staging procedures which has a major impact on patient management.
Journal ArticleDOI
Invasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence
TL;DR: Invasive clinical staging of NSCLC can be performed effectively by TBNA, TTNA, EUS-NA, or mediastinoscopy, dependent on the degree of suspicion for metastatic disease, the patient's comorbid illnesses, and the availability and performance characteristics of procedural options.